Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Statistical Analysis
3. Result
3.1. Reduction in Kawasaki Disease after Public Health Interventions for the COVID-19 Pandemic in 2020
3.2. No Change of the Presentation Kawasaki Disease and Percentage of IVIG Resistance in 2020
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wang, C.L.; Wu, Y.T.; Liu, C.A.; Kuo, H.C.; Yang, K.D. Kawasaki disease: Infection, immunity and genetics. Pediatr. Infect. Dis. J. 2005, 24, 998–1004. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.H.; Lin, K.M.; Ho, S.C.; Yan, J.H.; Lo, M.H.; Kuo, H.C. Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study. Front. Pediatr. 2019, 7, 121. [Google Scholar] [CrossRef] [PubMed]
- Rowley, A.H.; Shulman, S.T. The Epidemiology and Pathogenesis of Kawasaki Disease. Front. Pediatr. 2018, 6, 374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, Y.H.; Li, S.C.; Huang, L.H.; Chen, P.C.; Lin, Y.Y.; Lin, C.C.; Kuo, H.C. Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease. Oncotarget 2017, 8, 11249–11258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733. [Google Scholar] [CrossRef]
- Peaper, D.R.; Murdzek, C.; Oliveira, C.R.; Murray, T.S. Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Children in a Large Regional US Health System During the Coronavirus Disease 2019 Pandemic. Pediatr. Infect. Dis. J. 2020. publish ahead of print. [Google Scholar] [CrossRef]
- Balasubramanian, S.; Rao, N.M.; Goenka, A.; Roderick, M.; Ramanan, A.V. Coronavirus Disease (COVID-19) in Children—What We Know So Far and What We Do Not? Indian Pediatr. 2020, 57, 435–442. [Google Scholar] [CrossRef]
- Dong, Y.; Wang, L.; Burgner, D.P.; Miller, J.E.; Song, Y.; Ren, X.; Li, Z.; Xing, Y.; Ma, J.; Sawyer, S.M.; et al. Infectious diseases in children and adolescents in China: Analysis of national surveillance data from 2008 to 2017. BMJ 2020, 369, m1043. [Google Scholar] [CrossRef] [Green Version]
- Feldstein, L.R.; Rose, E.B.; Horwitz, S.M.; Collins, J.P.; Newhams, M.M.; Son, M.B.F.; Newburger, J.W.; Kleinman, L.C.; Heidemann, S.M.; Martin, A.A.; et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020, 383, 334–346. [Google Scholar] [CrossRef]
- Fabi, M.; Filice, E.; Andreozzi, L.; Conti, F.; Gabrielli, L.; Balducci, A.; Vergine, G.; Cicero, C.; Iughetti, L.; Guerzoni, M.E.; et al. Spectrum of cardiovascular diseases in children during high peak COVID-19 period infection in Northern Italy: Is there a link? J. Pediatr. Infect. Dis. Soc. 2020. [Google Scholar] [CrossRef]
- Swann, O.V.; Holden, K.A.; Turtle, L.; Pollock, L.; Fairfield, C.J.; Drake, T.M.; Seth, S.; Egan, C.; Hardwick, H.E.; Halpin, S.; et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: Prospective multicentre observational cohort study. BMJ 2020, 370, m3249. [Google Scholar] [CrossRef] [PubMed]
- Consiglio, C.R.; Cotugno, N.; Sardh, F.; Pou, C.; Amodio, D.; Rodriguez, L.; Tan, Z.; Zicari, S.; Ruggiero, A.; Pascucci, G.R.; et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell 2020, 183, 968–981.e7. [Google Scholar] [CrossRef] [PubMed]
- Lin, C.F.; Huang, Y.H.; Cheng, C.Y.; Wu, K.H.; Tang, K.S.; Chiu, I.M. Public Health Interventions for the COVID-19 Pandemic Reduce Respiratory Tract Infection-Related Visits at Pediatric Emergency Departments in Taiwan. Front. Public Health 2020, 8, 604089. [Google Scholar] [CrossRef]
- Wang, C.J.; Ng, C.Y.; Brook, R.H. Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA 2020. [Google Scholar] [CrossRef] [PubMed]
- Lien, W.C.; Wu, J.L.; Tseng, W.P.; Ko, P.C.-I.; Chen, S.Y.; Tsai, M.S.; Chang, W.T.; Huang, C.H.; Chen, S.C. Fight COVID-19 Beyond the Borders: Emergency Department Patient Diversion in Taiwan. Ann. Emerg. Med. 2020, 75, 785–787. [Google Scholar] [CrossRef]
- Summers, J.; Cheng, H.Y.; Lin, H.H.; Barnard, L.T.; Kvalsvig, A.; Wilson, N.; Baker, M.G. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg. Health West. Pac. 2020, 4, 100044. [Google Scholar] [CrossRef]
- Chan, J.F.; Yuan, S.; Zhang, A.J.; Poon, V.K.; Chan, C.C.; Lee, A.C.; Fan, Z.; Li, C.; Liang, R.; Cao, J.; et al. Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19). Clin. Infect. Dis. 2020, 71, 2139–2149. [Google Scholar] [CrossRef]
- Hasegawa, K.; Tsugawa, Y.; Cohen, A.; Camargo, C.A., Jr. Infectious Disease-related Emergency Department Visits Among Children in the US. Pediatr. Infect. Dis. J. 2015, 34, 681–685. [Google Scholar] [CrossRef] [Green Version]
- Fung, I.C.; Cairncross, S. Effectiveness of handwashing in preventing SARS: A review. Trop. Med. Int. Health 2006, 11, 1749–1758. [Google Scholar] [CrossRef]
- McCrindle, B.W.; Rowley, A.H.; Newburger, J.W.; Burns, J.C.; Bolger, A.F.; Gewitz, M.; Baker, A.L.; Jackson, M.A.; Takahashi, M.; Shah, P.B.; et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017, 135, e927–e999. [Google Scholar] [CrossRef]
- Huang, Y.H.; Lo, M.H.; Cai, X.Y.; Liu, S.F.; Kuo, H.C. Increase expression of CD177 in Kawasaki disease. Pediatr. Rheumatol. Online J. 2019, 17, 13. [Google Scholar] [CrossRef] [Green Version]
- Chang, L.S.; Kuo, H.C. The role of corticosteroids in the treatment of Kawasaki disease. Expert Rev. Anti-Infect. Ther. 2020, 18, 155–164. [Google Scholar] [CrossRef] [PubMed]
- Tsai, C.M.; Chu, C.H.; Liu, X.; Weng, K.P.; Liu, S.F.; Huang, Y.H.; Kuo, H.C. A novel score system of blood tests for differentiating Kawasaki disease from febrile children. PLoS ONE 2021, 16, e0244721. [Google Scholar] [CrossRef] [PubMed]
- Kang, J.M.; Kim, Y.E.; Huh, K.; Hong, J.; Kim, D.W.; Kim, M.Y.; Jung, S.Y.; Kim, J.H.; Jung, J.; Ahn, J.G. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation 2021, 143, 2508–2510. [Google Scholar] [CrossRef] [PubMed]
- Hartman, H.E.; Sun, Y.; Devasia, T.P.; Chase, E.C.; Jairath, N.K.; Dess, R.T.; Jackson, W.C.; Morris, E.; Li, P.; Hochstedler, K.A.; et al. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic. JAMA Oncol. 2020, 6, 1881–1889. [Google Scholar] [CrossRef] [PubMed]
- Kuo, H.C. Kawasaki-like disease among Italian children in the COVID-19 era. J. Pediatr. 2020, 224, 179–183. [Google Scholar] [CrossRef] [PubMed]
- Dufort, E.M.; Koumans, E.H.; Chow, E.J.; Rosenthal, E.M.; Muse, A.; Rowlands, J.; Barranco, M.A.; Maxted, A.M.; Rosenberg, E.S.; Easton, D.; et al. Multisystem Inflammatory Syndrome in Children in New York State. N. Engl. J. Med. 2020, 383, 347–358. [Google Scholar] [CrossRef] [PubMed]
- Dominguez, S.R.; Anderson, M.S.; Glode, M.P.; Robinson, C.C.; Holmes, K.V. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J. Infect. Dis. 2006, 194, 1697–1701. [Google Scholar] [CrossRef] [Green Version]
- Chang, L.Y.; Lu, C.Y.; Shao, P.L.; Lee, P.I.; Lin, M.T.; Fan, T.Y.; Cheng, A.L.; Lee, W.L.; Hu, J.J.; Yeh, S.J.; et al. Viral infections associated with Kawasaki disease. J. Formos. Med. Assoc. 2014, 113, 148–154. [Google Scholar] [CrossRef] [Green Version]
- Berardicurti, O.; Conforti, A.; Ruscitti, P.; Cipriani, P.; Giacomelli, R. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection. Expert Rev. Clin. Immunol. 2020, 16, 1205–1215. [Google Scholar] [CrossRef] [PubMed]
- Escobar, L.E.; Molina-Cruz, A.; Barillas-Mury, C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc. Natl. Acad. Sci. USA 2020, 117, 17720–17726. [Google Scholar] [CrossRef]
- Fukuda, S.; Kaneta, M.; Miyake, M.; Ohya, T.; Miyakawa, K.; Iwamoto, M.; Ito, S. A case of multisystem inflammatory syndrome in children in a japanese boy: With discussion of cytokine profile. Mod. Rheumatol. Case Rep. 2021, 1–11. [Google Scholar] [CrossRef]
- Choe, Y.J.; Choi, E.H.; Choi, J.W.; Eun, B.W.; Eun, L.Y.; Kim, Y.J.; Kim, Y.H.; Kim, Y.A.; Kim, Y.K.; Kwak, J.H.; et al. Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea. Emerg. Infect. Dis. 2021, 27, 1196–1200. [Google Scholar] [CrossRef]
- Curtis, N.; Sparrow, A.; Ghebreyesus, T.A.; Netea, M.G. Considering BCG vaccination to reduce the impact of COVID-19. Lancet 2020, 395, 1545–1546. [Google Scholar] [CrossRef]
- Khan, I.; Li, X.A.; Law, B.; In U, K.; Pan, B.Q.; Lei, C.; Hsiao, W.W. Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children. Future Microbiol. 2020, 15, 591–600. [Google Scholar] [CrossRef]
- Guo, H.; Callaway, J.B.; Ting, J.P. Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat. Med. 2015, 21, 677–687. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guo, M.M.; Tseng, W.N.; Ko, C.H.; Pan, H.M.; Hsieh, K.S.; Kuo, H.C. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy 2015, 70, 310–318. [Google Scholar] [CrossRef] [PubMed]
- Jacob, C.O. On the genetics and immunopathogenesis of COVID-19. Clin. Immunol. 2020, 220, 108591. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.; Lee, H.; Song, K.H.; Kim, E.S.; Park, J.S.; Jung, J.; Ahn, S.; Jeong, E.K.; Park, H.; Kim, H.B. Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea. Clin. Infect. Dis. 2020, 73, e132–e140. [Google Scholar] [CrossRef] [PubMed]
- Ruan, F.; Yang, T.; Ma, H.; Jin, Y.; Song, S.; Fontaine, R.E.; Zhu, B.P. Risk factors for hand, foot, and mouth disease and herpangina and the preventive effect of hand-washing. Pediatrics 2011, 127, e898–e904. [Google Scholar] [CrossRef] [Green Version]
- Harahsheh, A.S.; Dahdah, N.; Newburger, J.W.; Portman, M.A.; Piram, M.; Tulloh, R.; McCrindle, B.W.; de Ferranti, S.D.; Cimaz, R.; Truong, D.T.; et al. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J. Pediatr. 2020, 222, 261–262. [Google Scholar] [CrossRef]
2018 | 2019 | 2020 | |
---|---|---|---|
January | 11 | 11 | 16 |
February | 11 | 17 | 28 |
March | 23 | 21 | 16 |
April | 25 | 23 | 14 |
May | 22 | 22 | 11 |
June | 20 | 20 | 12 |
July | 19 | 32 | 14 |
August | 26 | 25 | 13 |
September | 28 | 21 | 10 |
October | 28 | 16 | 10 |
November | 18 | 26 | 9 |
December | 16 | 17 | 20 |
Total | 247 | 251 | 173 |
2018 | 2019 | 2020 | p-Value | |
---|---|---|---|---|
Cases in KD Center (% of CGMH Network) | 54 (21.9) | 49 (19.5) | 25 (14.5) | |
Male Gender (%) | 53.7 | 51.0 | 64.0 | 0.559 |
Age (Year) (Mean ± SE) | 2.2 ± 0.2 | 1.9 ± 0.3 | 2.2 ± 0.3 | 0.757 |
Typical KD (%) | 73.1 | 74.5 | 80.0 | 0.801 |
IVIG Resistance (%) | 14.8 | 6.1 | 8.0 | 0.319 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yang, Y.-L.; Kuo, H.-C. Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan. Children 2021, 8, 623. https://doi.org/10.3390/children8080623
Yang Y-L, Kuo H-C. Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan. Children. 2021; 8(8):623. https://doi.org/10.3390/children8080623
Chicago/Turabian StyleYang, Ya-Ling, and Ho-Chang Kuo. 2021. "Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan" Children 8, no. 8: 623. https://doi.org/10.3390/children8080623